Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2016 Jan 21;529(7586):289-90.
doi: 10.1038/nature16863. Epub 2016 Jan 6.

Cancer: Bet on Drug Resistance

Affiliations
Comment

Cancer: Bet on Drug Resistance

Jeff Settleman. Nature. .

Comment on

  • Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer.
    Shu S, Lin CY, He HH, Witwicki RM, Tabassum DP, Roberts JM, Janiszewska M, Huh SJ, Liang Y, Ryan J, Doherty E, Mohammed H, Guo H, Stover DG, Ekram MB, Brown J, D'Santos C, Krop IE, Dillon D, McKeown M, Ott C, Qi J, Ni M, Rao PK, Duarte M, Wu SY, Chiang CM, Anders L, Young RA, Winer E, Letai A, Barry WT, Carroll JS, Long H, Brown M, Liu XS, Meyer CA, Bradner JE, Polyak K. Shu S, et al. Nature. 2016 Jan 21;529(7586):413-417. doi: 10.1038/nature16508. Epub 2016 Jan 6. Nature. 2016. PMID: 26735014 Free PMC article.

Similar articles

See all similar articles

Cited by 7 articles

See all "Cited by" articles

References

    1. Oncogene. 2010 Aug 26;29(34):4741-51 - PubMed
    1. Cold Spring Harb Perspect Biol. 2014 Dec 01;6(12):a018663 - PubMed
    1. Nature. 2015 Sep 24;525(7570):543-547 - PubMed
    1. Future Oncol. 2012 Aug;8(8):999-1014 - PubMed
    1. Nature. 2015 Sep 24;525(7570):538-42 - PubMed

MeSH terms

LinkOut - more resources

Feedback